GRTX

Galera Therapeutics, Inc.

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Emerald Bioventures, LLC10 Percent Owner
--20.8k shares
Grant / ExerciseMay 15, 2026
Disclosure amount unavailable20.8k shares
--
--
Emerald Bioventures, LLC10 Percent Owner
--61M shares
Grant / ExerciseMay 15, 2026
Disclosure amount unavailable20.8M shares
--
--
Chang Nancy TDirector, 10 Percent Owner:
--661.3 shares
Grant / ExerciseApr 7, 2026
Disclosure amount unavailable1.2k shares
--
--
Chang Nancy TDirector, 10 Percent Owner:
--8.8M shares
Grant / ExerciseApr 7, 2026
Disclosure amount unavailable1.2M shares
--
--
Friedman Michael R.Director
--3k shares
Grant / ExerciseApr 7, 2026
Disclosure amount unavailable5.3k shares
--
--
Friedman Michael R.Director
--5.3M shares
Grant / ExerciseApr 7, 2026
Disclosure amount unavailable5.3M shares
--
--

News

businesswire.comGRTX Stock Alert: Halper Sadeh LLC is Investigating Whether Galera Therapeutics, Inc. is Obtaining a Fair Price for its Shareholdersbusinesswire.comApr 14globenewswire.comGalera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placementglobenewswire.comApr 14globenewswire.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Galera Therapeutics, Inc. (OTCMKTS: GRTX)globenewswire.comApr 14businesswire.comObsidian Therapeutics and Galera Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placementbusinesswire.comApr 14